Dec 1
|
Pfizer stock falls, drops work on twice-daily obesity pill
|
Dec 1
|
Pfizer’s Weight-Loss Drug Won’t Enter a Phase 3 Trial. The Stock Drops.
|
Dec 1
|
Pfizer Stock Heads for Lowest Level Since 2020 After Obesity-Drug Setback
|
Dec 1
|
US STOCKS-Wall St set for lower open in run-up to Powell's remarks
|
Dec 1
|
Pfizer drops plan for twice-daily obesity pill due to side effects
|
Sep 30
|
Could Viatris Stock Help You Become a Millionaire?
|
Sep 30
|
Moderna's Shares Could Take Off if These 2 Things Happen
|
Sep 29
|
Unveiling Pfizer (PFE)'s Value: Is It Really Priced Right? A Comprehensive Guide
|
Sep 29
|
Why Pfizer and BioNTech Stocks Zoomed Higher Today
|
Sep 29
|
12 Best Places to Retire in Greece
|
Sep 29
|
Structure Stock Soars. Its Obesity Pill Could Challenge Lilly, Novo.
|
Sep 29
|
Upstart Weight-Loss Drugmaker Jumps 75% on Strong Test Results
|
Sep 29
|
3 Stocks to Focus on as Demand for Obesity Drugs Booms
|
Sep 29
|
Where Will Pfizer Be in 5 Years?
|
Sep 29
|
Bud Light boycott movement goes after Taylor Swift and Travis Kelce
|
Sep 29
|
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
|
Sep 28
|
2 Undervalued High-Yield Names for High Total Returns
|
Sep 28
|
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Resilience
|
Sep 28
|
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Robust Resilience
|
Sep 28
|
Covid-19 Vaccine Uptake Could Beat Expectations, Poll Indicates
|